US equities
|
MU
$983.23
▲+5.86%
META
$612.49
▼-1.24%
GOOGL
$324.89
▲+1.34%
NVDA
$215.38
▼-1.17%
MSFT
$531.01
▼-0.06%
TSLA
$404.22
▼-0.80%
SPCX
$145.23
▼-2.25%
SNDK
$1,404.77
▲+7.66%
MU
$983.23
▲+5.86%
META
$612.49
▼-1.24%
GOOGL
$324.89
▲+1.34%
NVDA
$215.38
▼-1.17%
MSFT
$531.01
▼-0.06%
TSLA
$404.22
▼-0.80%
SPCX
$145.23
▼-2.25%
SNDK
$1,404.77
▲+7.66%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Ainos, Inc. - warrants
(NQ:
AIMDW
)
0.0305
-0.0274 (-47.32%)
Delayed Quote
Updated: 12:18 PM EDT, Oct 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Ainos, Inc. - warrants
< Previous
1
2
3
4
5
6
Next >
Ainos Completes VELDONA Technology Transfer, Triggering $600,000 License Payment
September 30, 2026
Partner's Written Confirmation Fulfills Payment Conditions; Initial License Fee Payable Within 15 Business Days
From
Ainos, Inc.
Via
ACCESS Newswire
Ainos Completes Delivery of 1,400 AI Nose Systems to ASE Under $2.1 Million, Three-Year Contract
September 29, 2026
Preparations underway for a larger-scale second-phase deployment specified in the existing MOU, building on first-phase deployment experience Advanced packaging deployment marks a major step for Ainos'...
From
Ainos, Inc.
Via
ACCESS Newswire
Ainos Details Partner-Funded VELDONA Development and Revenue Opportunities, Reinforcing Focus on Chemical Intelligence
September 28, 2026
Initial license payment tied to near-term contractual delivery; additional payment opportunities may arise during development, before drug approval Partner assumes assigned clinical and regulatory...
From
Ainos, Inc.
Via
ACCESS Newswire
Ainos and BioPhoenix Sign VELDONA License Agreement, Establishing a Potential $10 Million Collaboration Framework
September 24, 2026
Partner-funded development marks an important milestone for VELDONA, with BioPhoenix funding and advancing clinical and regulatory development for two initial indications Development funding is...
From
Ainos, Inc.
Via
ACCESS Newswire
VASRO Research Highlights Ainos' New Order, Semiconductor Commercial Momentum and 1 Billion+ Chemical Dataset
September 16, 2026
Report points to front-end semiconductor orders, a $2.1 million back-end program and continued dataset expansion as key indicators of Ainos' growing commercial scale
From
Ainos, Inc.
Via
ACCESS Newswire
Ainos Advances AI Nose into Commercial Deployment in Front-End Semiconductor Manufacturing
September 14, 2026
Initial commercial orders mark progress toward broader commercial adoption and support revenue-generation opportunities beginning in 2H 2026 Proprietary real-world chemical dataset surpasses 1 billion...
From
Ainos, Inc.
Via
ACCESS Newswire
Ainos Secures Three Japanese Robotics Patents, Advancing Chemical Perception for the Physical AI Era
September 09, 2026
New patents cover electronic nose integration with robotics, expanding Ainos' portfolio of 124 patent assets worldwide across chips, sensing architectures, chemical molecules and real-world...
From
Ainos, Inc.
Via
ACCESS Newswire
Ainos Launches Atmosphere Engine, Extending Physical AI from Environmental Sensing to Active Environmental Management
August 19, 2026
From
Ainos, Inc.
Via
ACCESS Newswire
Ainos Unveils Next-Generation AI Nose, Advancing the Infrastructure for Chemical Intelligence
August 17, 2026
From
Ainos, Inc.
Via
ACCESS Newswire
Ainos Surpasses 878 Million Real-World Data Points, Up 43% in 23 Days as 1,400-System AI Nose Semiconductor Deployment Advances
August 13, 2026
From
Ainos, Inc.
Via
ACCESS Newswire
Ainos to Showcase Environmental Intelligence for Physical AI at SEMICON Taiwan 2026
August 12, 2026
From
Ainos, Inc.
Via
ACCESS Newswire
VASRO Research Highlights Ainos' Progress in Scaling Smell AI Commercialization and Compounding Its Smell ID Dataset
August 10, 2026
From
Ainos, Inc.
Via
ACCESS Newswire
Zacks Small-Cap Research Covers Ainos' AI Nose Platform and Expansion of Smell AI Applications
August 06, 2026
From
Ainos, Inc.
Via
ACCESS Newswire
Ainos Reports Second Quarter 2026 Results and Highlights Continued AI Nose Execution Across Industrial, Healthcare Infrastructure and Robotics Markets
August 03, 2026
From
Ainos, Inc.
Via
ACCESS Newswire
Ainos Expands Smell AI With Growing Real-World Scent Dataset for Physical AI
July 21, 2026
From
Ainos, Inc.
Via
ACCESS Newswire
VASRO Research Highlights Ainos' Expansion of Smell AI Into Patient-Level Breath Intelligence
June 22, 2026
From
Ainos, Inc.
Via
ACCESS Newswire
Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program
June 17, 2026
From
Ainos, Inc.
Via
ACCESS Newswire
Ainos Releases 2026 Mid-Year CEO Letter to Shareholders
June 08, 2026
Via
ACCESS Newswire
VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations
June 05, 2026
Via
ACCESS Newswire
Zacks SCR Discusses Ainos' Expansion of Smell AI into Healthcare Infrastructure Through NTUH Study
June 03, 2026
Via
ACCESS Newswire
Ainos Launches Smell AI Study at National Taiwan University Hospital for ER Overcrowding and Respiratory Infection Risk Analysis
June 01, 2026
Via
ACCESS Newswire
VASRO Research Highlights Ainos AI Nose Commercialization Progress and Semiconductor Industry Shift Toward AI-Driven Environmental Intelligence
May 20, 2026
Via
ACCESS Newswire
Zacks Small-Cap Research Highlights Ainos' Smell AI Commercialization
May 18, 2026
Via
ACCESS Newswire
Ainos Reports First Quarter 2026 Financial Results and Highlights Smell AI Execution Across Semiconductors and Healthcare Infrastructure Markets
May 13, 2026
Via
ACCESS Newswire
Ainos Updates Standard Industrial Classification Code to Reflect Smell AI Business Focus
May 11, 2026
Via
ACCESS Newswire
VASRO: Ainos Expands Smell AI from Industrials into Healthcare Infrastructure, Reinforcing AI Infrastructure Positioning and Multi-Vertical Scalability
April 17, 2026
Via
ACCESS Newswire
VASRO Research Highlights Ainos' Smell AI Commercial Progress and 2026 Deployment Momentum
April 01, 2026
Via
ACCESS Newswire
Ainos Reports Full Year 2025 Financial Results and Highlights Commercial Momentum Entering 2026
March 30, 2026
Via
ACCESS Newswire
The Wall Street Journal Highlights Emerging "Smell AI" - Ainos Advances Commercial Deployment in Semiconductor Environments
March 19, 2026
Via
ACCESS Newswire
Water Tower Research Highlights Ainos' Scaling Momentum Across Semiconductor Value Chain
March 12, 2026
Via
ACCESS Newswire
< Previous
1
2
3
4
5
6
Next >
